Vanessa Van Edwards
Behavioral Researcher & Founder of Science of People | Bestselling Author of Captivate, Cues, and Conversation | Expert on Charisma, Communication & Human Behavior
Synthetic Biologist & Futurist | Co-founder, Genome Project-write | President, Humane Genomics | Co-author, The Genesis Machine
Andrew Hessel is one of the world's leading voices on synthetic biology — the field that treats DNA as a programming language and living cells as the next computing platform. Co-founder of the Genome Project-write and president of Humane Genomics, he brings a working scientist's precision and a futurist's sweep to audiences who need to understand a technology that will transform medicine, manufacturing, and biodefense.
Want to book Andrew Hessel as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Andrew Hessel is one of the world’s most distinctive voices at the intersection of biology, computing, and the future. A microbiologist and geneticist by training, he has spent his career advancing a single, radical proposition: that DNA is a programming language, living cells are the next computing platform, and we are now entering an era in which biology can be engineered with the same speed, precision, and creative freedom as software.
Science speaker Andrew Hessel is co-founder and chairman of the Genome Project-write (GP-write), the international scientific initiative working to synthesize large-scale genomes — including, ultimately, the human genome — from scratch. Where the original Human Genome Project read the code of life, GP-write aims to write it: a shift in ambition that Hessel has been pushing for since well before the scientific community was ready to discuss it seriously. He also serves as president of Humane Genomics, a company developing precision-engineered synthetic viruses as targeted cancer therapies, work that builds on his years as a Distinguished Researcher at Autodesk, where he led the first digital design and synthesis of a complete viral genome.
In 2022, Hessel co-authored The Genesis Machine: Our Quest to Rewrite Life in the Age of Synthetic Biology with futurist Amy Webb, published by PublicAffairs. The book was named a New Yorker Best Book of the Year, achieved Amazon bestseller status, and was recommended by McKinsey. Described by Nature as a “fascinating survey of the present and future of biotechnology” and by The New Yorker as a “road map for navigating its opportunities and perils,” it remains the clearest accessible account of synthetic biology’s trajectory and stakes.
Hessel’s work in recent years has expanded into biosecurity — the urgently underdeveloped question of how societies protect themselves in a world where biology is becoming as programmable as software. In October 2024, he co-organized GENESIS BIOSECURITY, an unconference in New York City that brought together biosecurity experts, cybersecurity professionals, government officials, designers, and engineers to map the future of biological defense. He advises government bodies including the Department of Defense and the FBI, and regularly engages scientific and policy audiences on what the programmability of life means for national security, public health infrastructure, and governance.
As a speaker, Andrew Hessel translates one of the most consequential scientific revolutions of our time into terms that resonate with business leaders, policymakers, and technologists who need to understand it — not as a distant threat or a speculative promise, but as a present reality with immediate organizational implications. His talks have reached audiences at Jeff Bezos’s exclusive MARS conference, EY, Singularity University, and major government and scientific institutions. Contact Aurum Speakers Bureau to book Andrew Hessel for your next event.
Hessel's signature talk frames synthetic biology not as a medical specialty but as a computing revolution — one in which biology is the platform, DNA is the code, and cells are the devices. He traces the arc from reading the genome to writing it, explains why this transition is accelerating faster than most organizations realize, and shows how the tools being built today will put the ability to design living systems into the hands of anyone with a laptop and a browser. This keynote consistently reorients the mental models of technical and non-technical audiences alike.
Drawing from his co-authored book with futurist Amy Webb, Hessel examines the full landscape of synthetic biology — from mRNA vaccines and lab-grown food to personalized cancer therapies and engineered ecosystems — and frames the key governance, ethics, and business strategy questions that are still largely unresolved. Who decides what gets engineered? How do regulatory frameworks keep pace? What does this mean for pharma, agriculture, materials science, and national security? A keynote designed for senior decision-makers who need a clear-eyed, non-sensationalized account of where this field is going and what it demands of their organizations.
As biology becomes an information technology, it inherits both the power and the vulnerabilities of the digital world. Hessel has spent years working at the intersection of synthetic biology and biosecurity, advising the DoD, FBI, and other government bodies on the threat landscape that emerges when DNA can be designed on a computer and synthesized in a lab. This keynote examines what a credible biodefense posture looks like in 2025 and beyond — covering biosurveillance, rapid countermeasure development, dual-use research governance, and the institutional readiness gaps that currently leave most organizations exposed.
Hessel has long argued that the logical endpoint of genomic medicine is not better drugs for populations but precisely targeted therapies for individuals — an n-of-1 model in which diagnostics and treatments are designed specifically for one patient's biology. His work at Humane Genomics on synthetic oncolytic viruses, and his observation of early-stage personalized cancer pipelines, has sharpened his view of where medicine is going and how quickly. This keynote is particularly valuable for audiences in healthcare, pharmaceutical strategy, and health insurance who are trying to understand how the transition from population medicine to precision medicine will unfold — and who it will disrupt first.
| Basic Data Protection Information | |
|---|---|
| Data controller | AURUM SPEAKERS BUREAU S.L. |
| Address | Parc Audiovisual de Catalunya 1, Oficina S11, 08225 Terrassa, Spain |
| Purposes | We will use your data to respond to your requests and deliver our services to you. |
| Marketing | We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Lawful basis | We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Recipients | Generally, only our members of staff who have been duly authorised may access the data that you have provided. |
| Your Rights | You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website. |
| Additional Information | For more information, please see “PRIVACY POLICY” on our website. |